Please assess the completion status of the following clinical trial:

Trial Title: COlchicine in Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Adult patients awaiting elective cardiac surgery (CABG and/or AVR (aortic valve replacement), who are willing and able to give informed consent for participation in the study and who are in sinus rhythm and not taking any antiarrhythmic medication, except beta-adrenergic blocking agents, at the time before surgery.~Exclusion Criteria:~* History of persistent or long-term atrial fibrillation/atrial flutter~* Congenital heart disease, except the bicuspid AV~* Frequent VE/SVE, AV block 2-3 degrees~* Use of corticosteroids during the last month~* Taking any antiarrhythmic drugs, except beta-blockers, within the last 1 month~* Prior open heart surgery~* Moderate to severe renal failure (creatinine clearance \< 50 ml / min)~* History of obstructive hepato-biliary disease or other serious hepatic disease~* Significant mitral valve disease (moderate or severe mitral regurgitation-eg. \> grade II and/or mitral stenosis \& mitral annular calcification).~* Patient participation in another clinical trial

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Colchicine (Type: EXPERIMENTAL): Colchicine 1 mg day (COLCHICINA LIRCA ® ACARPIA Farmaceutici S.r.l.)
- Placebo (Type: PLACEBO_COMPARATOR): Sugar pill

Based on this trial design, predict the completion outcome and termination type (if applicable).